G-Series

DexCom, Inc. (NASDAQ: DXCM) shares are trading lower after a new report from Spruce Point Capital argued the stock could fall 45-60 percent. The San Diego-based company manufacturers continuous glucose monitoring systems for diabetic patients. Until now, the company’s G-Series model has been...